Early Vascular Adjustments During Hypertensive Pregnancy (EVA)
Personalized Hemodynamically Guided Antihypertensive Treatment in Pregnant Women With Mild to Moderate Hypertension: a Randomized Controlled Trial
Sponsor: Maastricht University Medical Center
This PHASE4 trial investigates Hypertension, Pregnancy-Induced and Pre-Eclampsia and is currently ongoing. Maastricht University Medical Center leads this study, which shows 10 recorded versions since 2015 — indicating substantial longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE4
Status: Unknown Status → Unknown
-
May 2023 — Jul 2024 [monthly]
Unknown Status PHASE4
Status: Recruiting → Unknown Status
-
Apr 2021 — May 2023 [monthly]
Recruiting PHASE4
-
Jan 2021 — Apr 2021 [monthly]
Recruiting PHASE4
▶ Show 5 earlier versions
-
Nov 2019 — Jan 2021 [monthly]
Recruiting PHASE4
-
Jun 2018 — Nov 2019 [monthly]
Recruiting PHASE4
-
May 2018 — Jun 2018 [monthly]
Recruiting PHASE4
-
Feb 2017 — May 2018 [monthly]
Recruiting PHASE4
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE4
First recorded
Jan 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Maastricht University Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .